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Abstract: COPD is a leading cause of morbidity and mortality, characterized by a chronic 
abnormal inﬂ  ammatory response to noxious agents. Apoptosis is a physiologic process, 
critical to cellular homeostasis, in which cell death follows a programmed sequence of events. 
Apoptosis has been recognized to play an important role in clinical and experimental models 
of lung diseases. Abnormal apoptotic events in smokers’ and in emphysematous lungs have 
been shown in epithelial and endothelial lung cells, neutrophils, lymphocytes, and myocytes. 
Many factors associated with COPD, including cigarette smoke, have the potential to cause 
apoptosis of alveolar epithelial cells, the main sites of vascular endothelial growth factor (VEGF) 
production. The decreased expression of VEGF, a known survival factor for endothelial cells, 
and its receptor, results in lung septal endothelial cell death, leading perhaps to the emphysema 
observed in COPD. In smokers who develop COPD there is an activation of adaptive immunity, 
with an inﬁ  ltration of CD4+ and, especially, CD8 + cells. CD8 + cells are cytotoxic to epithelial 
cells through the release of granzymes and perforin, which can further induce apoptosis of 
alveolar cells. Moreover, any reduction in neutrophil apoptosis or dysregulation of macrophage 
uptake of apoptotic neutrophils could lead to chronic inﬂ  ammation and tissue injury. Increased 
rates of T-cell apoptosis may lead to a defective immune response to infective organisms, 
contributing to the high frequency of infections seen in COPD. Increased apoptosis of skeletal 
muscle could be responsible for the skeletal muscle atrophy, the main cause of unexplained 
weight loss in patients with COPD. This paper is a review of the current knowledge on the 
apoptotic pathways involved in COPD pathogenesis and their interaction with other known 
contributing factors.
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Introduction
COPD is a leading cause of chronic morbidity and mortality worldwide, with a sub-
stantial economic and social burden (Siafakas et al 1995; Celli et al 2004; Pauwels and 
Rabe 2004). The 2002 WHO World Health Report listed COPD as the ﬁ  fth leading 
cause of death in the world and further increases in its prevalence and mortality are 
expected in the coming decades (WHO 2002; Pauwels and Rabe 2004). Recently, 
the ATS–ERS Task Force has published a document on the pathogenesis, diagnosis, 
monitoring, and management of COPD (Celli et al 2004). The latest deﬁ  nition of COPD 
according to this document notes that COPD is “characterised by airﬂ  ow limitation 
that is not fully reversible... is usually progressive and is associated with an abnormal 
inﬂ  ammatory response of the lungs to noxious particles or gases, primarily caused by 
cigarette smoking ... it also produces signiﬁ  cant systemic consequences.” (Celli et al 
2004). Although signiﬁ  cant progress has been made on the pathogenesis of COPD, 
the overall picture remains unclear.
Apoptosis, programmed cell death, is a highly ordered physiologic process by which 
useless, irreparably damaged or unwanted cells are eliminated throughout life.International Journal of COPD 2006:1(2) 162
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This process has attracted great attention in recent years, 
though the lung has been relatively little investigated. 
Elucidating the regulating mechanisms of apoptosis in 
lung cells should contribute to the understanding of the 
pathophysiology of lung disorders and allow identiﬁ  cation 
of speciﬁ  c therapeutic targets (Plataki et al 2005).
This review focuses on the existing literature on 
apoptosis in COPD, and the potential role of apoptosis on 
COPD pathogenesis. A synopsis of the relevant literature is 
presented in Table 1.
Apoptosis
Apoptosis, “normal” or “programmed” cell death, is an 
evolutionarily conserved, innate process by which cells 
systematically inactivate, disassemble, and degrade their 
own structural and functional components. The term 
“apoptosis” was ﬁ  rst introduced by Kerr et al in 1972 (Kerr 
et al 1972). It is a key mechanism allowing multicellular 
animals to tightly regulate cell growth (Baetu and Hiscott 
2002). Necrosis, “accidental” cell death, is a pathological 
process which occurs when cells are exposed to a serious 
physical or chemical insult. During necrosis loss of membrane 
integrity leads to the inﬂ  ux of water and extracellular ions. 
Intracellular organelles, most notably the mitochondria, 
and the entire cell swell and rupture and the cytoplasmic 
contents are released into the extracellular ﬂ  uid. During 
apoptosis coordinated morphological and biochemical 
changes occur within the nucleus, cytoplasm, organelles, and 
plasma membrane (Cohen 1993). Chromatin condenses and 
aggregates along the nuclear periphery and fragmentation of 
the nucleus occurs into chromatin containing fragments. Other 
cytoplasmic organelles remain structurally intact, although 
Table 1 Studies of apoptosis in COPD
Cell type Reference
Epithelial and endothelial cells
Human studies ↑apoptosis 
↓ VEGF, ↓ VEGF R2, ↓ VEGF KDR 
↑ bax
sFRP-1 gene expression 
↑ bad 
↑ Fas
↑ p53
↑ activated caspases 
↑ 4-HNE-modiﬁ  ed proteins
Segura-Valdez (2000); Majo (2001) 
Kasahara,Tuder, Cool (2000); Kasahara et al 
(2001)
 Yokohori (2004); Imai et al (2005) 
Imai and D’Armiento (2002)
Imai et al (2005)
Hodge et al (2005)
Hodge et al (2005)
Hodge et al (2005)
Rahman et al (2002)
Animal and in vitro 
studies
VEGF R blockade → ↑ apoptosis
injection of caspase 3 or Chariot → ↑ apoptosis 
PIGF transgenic mice → ↑ apoptosis, ↓ VEGF 
↓ ingestion of apoptotic cells by macrophages
Kasahara,   Tuder,   Taraseviciene-Stewart, et al
(2000); Tuder, Zhen, et al (2003)
Aoshiba et al (2003)
Tsao et al (2004)
Hodge, Hodge, Scicchitano, et al (2003)
Neutrophils
Human and animal 
studies
No difference in PBN apoptosis in stable COPD
↓ PBN apoptosis in acute exacerbations 
↑ Mac-1, ↓ L-selectin of PBN 
apoptosis of BALF granulocytes (horses)
Pletz et al (2004); Noguera et al (2004) 
Pletz et al (2004)
Noguera et al (2004)
Turlej et al (2001)
Lymphocytes
Human studies ↑apoptosis, ↑Fas, ↑TNF-a, ↑TNFR1, ↓bcl2 in PBT
↑ apoptosis, ↑p53, ↑ activated caspases in BALFT
Hodge, Hodge, Reynolds, et al (2003); Hodge et al
(2005)
Hodge et al (2005)
Skeletal myocytes
Human studies No difference in apoptosis between COPD-controls 
↓ apoptosis in COPD with low BMI
Gosker et al (2003) 
Agusti et al (2002)
Soluble apoptotic markers
Human studies ↑ plasma sFas in severe COPD 
No difference in plasma sFasL
Yasuda et al (1998) 
Yasuda et al (1998); Takabatake et al (2000)
Abbreviations: BALF, bronchoalveolar lavage ﬂ  uid; BALFT, BALF   T-cells; BMI, body mass index; sFRP-1, frizzled-related protein; 4-HNE, 4-Hydroxy-2-nonenal; KDR, kinase 
insert domain-containing receptor; PBN, peripheral blood neutrophils; PBT, peripheral blood T-cells; PIGF, placenta growth factor; R, receptor; sFas, soluble Fas receptor; sFasL; 
soluble Fas ligand; TNF-α, tumor necrosis factor-α; VEGF, vascular endothelial growth factor.International Journal of COPD 2006:1(2) 163
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pore formation in the mitochondrial membrane is associated 
with apoptosis. The cell rounds up, dissociates itself from 
its neighbors, and shrinks, throwing out protuberances 
that separate into membrane-bound “apoptotic bodies”, 
containing cytoplasmic organelles and nuclear material. 
Within tissues apoptotic bodies are rapidly phagocytosed 
by neighboring cells (Cohen 1993).
Apoptosis can be triggered through two major pathways, 
one implicating death receptor ligation and the other the 
release of cytochrome c from mitochondria (Baetu and 
Hiscott 2002) (Table 2). The death receptor pathway is 
initiated by the ligation of members of the tumor necrosis 
factor (TNF) family, such as TNF-α and Fas-ligand, to their 
respective ligands, TNF receptor 1, and Fas (Baetu and 
Hiscott 2002). These “death-inducing” receptors recruit the 
death-inducing signaling complex through interaction with 
adaptor proteins such as Fas associated death domain protein 
(FADD). In turn, FADD recruits caspase-8. Caspase-8 
activation leads to either direct activation of caspase-3, or 
to cleaving of Bid, a member of the bcl-2 family, which in 
turn targets mitochondria for cytochrome c release (Baetu 
and Hiscott 2002). The mitochondrial pathway can be 
triggered by both external and internal stimuli. Members 
of the bcl-2 family of proteins, like bcl-2, bax, and bad, 
gather at the surface of mitochondria, where they compete 
to regulate cytochrome c release, which leads to caspase-9 
activation. Bcl-2 is an antiapoptotic and bad and bax are 
proapoptotic members of this family (Baetu and Hiscott 
2002). Akt is a serine–threonine kinase that phospholylates 
and thereby inactivates the proapoptotic proteins bad and 
caspase 9, and elevates the expression of the antiapoptotic 
protein bcl-2 (Datta et al 1999). Both pathways converge at 
the level of caspase-3 activation. Caspases are proteolytic 
enzymes, the executioners of apoptosis. Caspase activation 
results in DNA laddering, characteristic of apoptotic cells, 
and to the cleavage of cytoskeletal proteins. p53 is a critical 
mediator of two different cellular responses following 
exposure to DNA damage: growth arrest in the G1 phase of 
the cell cycle or apoptosis in the case of irreparable damage 
(Canman and Kastan 1997). 4-Hydroxy-2-nonenal (4-HNE) 
is an end-product of lipid peroxidation, which is involved 
in provoking the toxic effects of oxidative stress to cells, 
promoting apoptosis (Rabacchi et al 2004). The frizzled-
related protein sFRP-1 plays a part in the disruption of 
the normal Wnt signaling status and may also promote the 
apoptotic process (Jones and Jomary 2002).
A number of methods are used for the detection 
of apoptosis. These assays try to measure one of the 
following apoptotic parameters: a) DNA fragmentation 
(eg, TdT-mediated dUTP nick end labeling, TUNEL); 
b) membrane alterations, such as phosphatidylserine 
translocation (eg, annexinV-propidium iodide staining); 
c) activation of caspases (eg, anti-active caspase 3 antibody); 
and d) detection of proteolytic cleavage products found 
in apoptotic cells (eg, anti-poly-ADP-ribose polymerase 
antibody, anti-fractin antibody). Apoptotic cells are also 
recognized by electron microscopy due to the characteristic 
morphological changes. Moreover, the expression of a number 
of genes and proteins involved in the regulation of apoptosis 
can also be studied by reverse transcription polymerase chain 
reaction (RT-PCR) or immunohistochemistry.
Apoptosis of epithelial and 
endothelial cells
Recently many reports have been published highlighting the 
presence of apoptosis in human COPD lungs and its role in 
the pathogenesis of emphysema (Shapiro 2000b). Pulmonary 
emphysema, deﬁ  ned as abnormal, permanent enlargement 
of airspaces distal to terminal bronchioles, accompanied by 
destruction of their walls, with or without obvious ﬁ  brosis, 
is a major component of COPD (Snider et al 1985). On the 
other hand, relatively little attention has been paid to the 
signiﬁ  cance of epithelial or endothelial apoptosis in chronic 
bronchitis.
Animal and in vitro studies
The importance of apoptosis in the pathogenesis of 
emphysema stems from animal studies. Kasahara, Tuder, 
Taraseviciene-Stewart, et al (2000) suggested that chronic 
blockade of vascular endothelial growth factor (VEGF) 
receptors induces alveolar cell apoptosis and emphysema.
Table 2 Markers upregulating (↑) or downregulating (↓) 
apoptosis in COPD
Apoptotic markers Apoptosis
bcl-2 ↓
bax ↑
bad ↑
Akt ↓
TNF-α↑
Fas–Fas ligand ↑
p53 ↑
4-Hydroxy-2-nonenal ↑
sFRP-1 ↑
Abbreviations: sFRP-1, frizzled-related protein; TNF-α, tumor necrosis factor-α.International Journal of COPD 2006:1(2) 164
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Indeed, treatment of rats with a VEGF receptor blocker 
induced alveolar septal cell apoptosis, a pruning of 
the pulmonary arterial tree and enlargement of the air 
spaces, indicative of emphysema. Treatment with a cas-
pase inhibitor prevented the septal cell apoptosis and 
emphysema caused by the VEGF receptor inhibitor. Aoshiba 
et al (2003) described the induction of emphysematous 
changes, including airspace enlargement, alveolar wall 
cell apoptosis (mainly epithelial cells), in mice treated with 
an intratracheal injection of active caspase-3 and Chariot, 
a protein transfection reagent, or nodularin, a proapoptotic 
serine–threonine kinase inhibitor. In addition, epithelial 
apoptosis and enhanced elastolytic activity were noted in 
bronchoalveolar lavage (BAL). In vitro ﬁ  ndings showed 
the destruction of the elastin layer beneath the type II cells 
that were undergoing apoptosis. In both of these studies, 
ﬁ  brosis or increased inﬁ  ltration of inﬂ  ammatory cells was 
absent. Oxidative stress has been shown to have a critical 
role in alveolar septal cell apoptosis and emphysema caused 
by VEGF receptor blockade (Tuder, Zhen, et al 2003). Rats 
treated with a VEGF receptor blocker showed increased 
alveolar septal cell apoptosis, airspace enlargement, and 
expression of markers of oxidative stress, all of which were 
prevented by a superoxide dismutase mimetic. Apoptosis 
predominated in areas of oxidative stress, and treatment with 
a broad-spectrum caspase inhibitor markedly reduced the 
expression of markers of oxidative stress. In lungs treated 
with both the VEGF receptor blocker and the superoxide 
dismutase mimetic, the preservation of lung structure was 
associated with enhanced phosphorylation of the prosurvival 
and antiapoptotic Akt. Moreover it has been reported that 
i.v. injection of alpha-1 antitrypsin prevents VEGF receptor 
blockade-induced emphysema in rats (Choe et al 2003). 
Increased alveolar septal cell apoptosis and pulmonary 
emphysema, with enlarged air spaces and enhanced 
pulmonary compliance, were also noted in placenta 
growth factor (PIGF)–transgenic mice, with constitutive 
overexpression of PIGF (Tsao et al 2004). PIGF is a VEGF 
homolog, which may function by modulating VEGF activity 
or by triggering its own intracellular signals, involving 
proliferation, apoptosis, or angiogenesis (Cao et al 1996; 
Autiero et al 2003). In these mice, apoptotic septal cells were 
type II pneumocytes. At the same time, the messenger RNA 
of VEGF and platelet–endothelial cell adhesion molecule-1, 
an endothelial cell marker, were downregulated indicating 
a reduced number of endothelial cells and their survival 
factor VEGF. An inﬂ  ammatory or ﬁ  brotic response was 
absent in these mice. In addition to an absolute increase 
in pro-apoptotic mechanisms, Hodge, Hodge, Scicchitano, 
et al (2003) suggested that impaired capacity for phagocytic 
clearance of apoptotic material may be a factor further 
contributing to emphysema pathogenesis. When incubating 
apoptotic airway epithelial cells with alveolar macrophages 
from BAL from COPD patients and control subjects, a 
signiﬁ  cantly reduced proportion of alveolar macrophages 
from COPD subjects ingested apoptotic airway epithelial 
cells compared with controls.
Human studies
Segura-Valdez et al (2000) were the ﬁ  rst to show increased 
apoptosis in the lungs of COPD patients. In their study, 
endothelial cells from capillaries and arterioles, and 
occasionally alveolar epithelial, interstitial, and inﬂ  amma-
tory cells, exhibited prominent intranuclear staining by in situ 
end labeling of fragmented DNA. In a report by Kasahara 
et al (2001), there was increased apoptosis of alveolar 
epithelial and endothelial cells in lung tissue samples 
obtained from patients with emphysema compared with 
lung samples from either nonsmokers or smokers without 
emphysema. Moreover, VEGF, VEGF receptor 2 (VEGF R2) 
protein, and mRNA expression were signiﬁ  cantly reduced 
in emphysema (Kasahara et al 2001). The authors proposed 
that epithelial and endothelial alveolar septal death due to 
a decrease of endothelial cell maintenance factors may be 
part of the pathogenesis of emphysema. It must be noted 
that in this study the septal structures in the emphysematous 
areas examined for the presence of apoptotic cells did not 
show clear signs of acute or chronic inﬂ  ammation. The 
same group has reported signiﬁ  cantly reduced expression 
of the VEGF receptor, kinase insert domain-containing 
receptor (KDR), in emphysematous lungs (Kasahara, Tuder, 
Cool, et al 2000). Yokohori et al (2004) also found that the 
fraction of the total alveolar wall cells undergoing apoptosis 
and proliferation was signiﬁ  cantly higher in patients with 
emphysema than in asymptomatic smokers and nonsmokers. 
Patients with emphysema also showed a signiﬁ  cant increase 
in the bax index, suggesting that the overexpression of bax 
protein may be involved in the apoptosis of the alveolar 
wall cells in these patients. Most of the apoptotic cells in 
this study were epithelial type-II cells. A study on tissue 
from the emphysematous lung areas of human patients 
by Imai et al (2005) showed that the apoptotic index was 
closely correlated with the severity of disease. They have 
also identiﬁ  ed the expression of the frizzled-related protein 
sFRP-1 gene, an inducer of apoptosis, in emphysema. 
In a recent study, Imai et al (2005) identiﬁ  ed extensive International Journal of COPD 2006:1(2) 165
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cell death by apoptosis, conﬁ  rmed with several different 
techniques, in the lung tissue of patients with emphysema. 
Apoptosis was inversely correlated with surface area. 
Bcl-2 expression was not detected in emphysematous 
lung, whereas bax and bad expression was. Bax staining 
was localized to alveolar epithelial cells and bad staining 
to both epithelial and mesenchymal cells (Imai et al 2005). 
Rahman et al (2002) investigated the presence of 4-HNE, 
a highly reactive diffusible product of lipid peroxidation 
which mediates oxidant-induced cell signaling and apop-
tosis, in lung tissue from subjects with and without COPD. 
The 4-HNE-modiﬁ  ed protein levels were elevated in airway 
and alveolar epithelial cells, endothelial cells, and neutro-
phils in COPD patients, compared with those in subjects 
without COPD. Moreover, there was a signiﬁ  cant inverse 
correlation between the levels of 4-HNE adducts in alveolar 
epithelium, airway endothelium, and neutrophils, and FEV1. 
TNF-α is also considered to play an important role in the 
induction of apoptosis, and allele 2 of the polymorphism 
at position −308 in the promoter of the TNF-α gene has 
been associated with increased TNF-α secretion in vitro 
(Sakao et al 2002). Sakao et al (2002) reported that the 
TNF-α-308*1/2 allele frequency was higher, though not 
signiﬁ  cantly, in COPD patients with more extensive emphy-
sema changes, as assessed by computed tomography (CT). 
Majo et al (2001) investigated the presence of apoptotic 
alveolar epithelial cells in the lung, as indirect evidence of 
T-cell-mediated cytotoxicity, through the cytolytic effect 
of CD8 + cells by perforin-mediated lysis and apoptosis 
(Chrysofakis et al 2004). It was found that apoptosis of 
alveolar wall cells in active smokers with emphysema 
increased together with the amount smoked and the num-
ber of CD8 + T-cells after a certain dose of smoking was 
reached, suggesting that cytotoxicity may play a role in the 
pathogenesis of emphysema (Majo et al 2001). Recently, in 
a study by Hodge et al (2005) using ﬂ  ow cytometric assays 
on cell populations obtained from bronchial brushing, both 
the percentage and absolute number of apoptotic bronchial 
epithelial cells was signiﬁ  cantly higher for patients with 
COPD than controls. They also noted increased expression 
of Fas, p53, and activated caspases by brushing-derived 
bronchial epithelial cells in COPD (Hodge et al 2005). 
Most of the above studies, however, were performed in 
lung tissue, whereas apoptotic cells lose their attachments 
with surrounding matrix and might therefore accumulate 
in airway lumen. Future studies, combining tissue and 
cytological (induced sputum and BAL) samples could reveal 
increased number of detached apoptotic cells.
Pathophysiologic implications
The above studies suggest that apoptosis plays a signiﬁ  cant 
role in emphysema development. The lung is unique because 
of its exposure to the external environment and high oxygen 
tension (Tuder, Petrache, et al 2003). Many factors associ-
ated with COPD are potential causes of apoptosis of alveolar 
epithelial cells (Hodge, Hodge, Scicchitano, et al 2003). 
These include the 5000-plus chemical compounds and free 
radical molecules present in cigarette smoke, increased pro-
duction of cytokines, neutrophil activity, and disruptions of 
epithelial cell–matrix interactions (Hodge, Hodge, Scicchi-
tano, et al 2003; Tuder, Petrache, et al 2003). It is possible 
that lung cell apoptosis, excessive proteolysis, and oxidative 
stress interact, leading to the destruction seen in emphysema 
(Tuder, Petrache, et al 2003) (Figure 1). Increased apoptosis 
of the epithelial cells, which are the main sites of VEGF 
production, may account for decreased VEGF expression. 
Gerber, Dixit, et al (1998) and Gerber, McMurtrey, et al 
(1998) reported that VEGF induces the expression of anti-
apoptotic proteins and Alon et al (1995) that VEGF acts as a 
survival factor for endothelial cells. If the amount of VEGF 
is sufﬁ  ciently reduced and the signal transduction via VEGF 
R2 is impaired, then alveolar endothelial cells could die as a 
consequence of a failing VEGF-dependent endothelial cell 
maintenance program. The compromised microcirculation 
resulting from endothelial cell damage may further promote 
pneumocyte cell death, perpetuating a vicious circle (Tsao 
et al 2004). However, it is still unclear whether pneumocytes 
and endothelial cells use this kind of cell communication. 
Furthermore, the presence of elevated markers of oxida-
tive stress in smokers’ lung is well documented, especially 
during exacerbations (Tsoumakidou et al 2005). Apoptotic 
death due to growth factor withdrawal is mediated by 
oxidative stress (Tuder, Zhen, et al 2003). The ﬁ  ndings of 
Tuder, Zhen, et al (2003), that apoptosis predominated in 
areas of oxidative stress, and that apoptosis blockade by 
a broad-spectrum caspase inhibitor markedly reduced the 
expression of markers of oxidative stress, suggest that there 
is a bidirectional relationship and a positive feedback loop 
between lung alveolar cell apoptosis and oxidative stress 
(Tuder, Zhen, et al 2003). Aoshiba et al (2003) provided 
evidence of detection of increased elastolytic activity in 
apoptotic lung epithelial cells, which may amplify the 
destruction of alveolar elastin. The subsequent destruction 
of the basement membrane and loss of cell–extracellular 
matrix attachments may lead to further apoptosis of the 
surrounding cells. This dynamic feedback mechanism could 
play a pivotal role in the regulation of local tissue proteolysis International Journal of COPD 2006:1(2) 166
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(Tuder, Petrache, et al 2003). Finally, the damaging effects 
of apoptosis could be ampliﬁ  ed by reduced clearance of 
these cells and persistence of apoptotic cell products, as 
suggested by Hodge, Hodge, Scicchitano et al (2003). 
Proteases derived from the inﬂ  ammatory reaction present 
in COPD can hinder apoptotic cell recognition and proper 
uptake (Vandivier et al 2002; Tuder, Petrache, et al 2003). 
Although cigarette smoking has been shown to induce 
apoptosis of bronchial epithelial cells in vitro, in a study 
by Hodge et al (2005) cessation of smoking did not reduce 
the increased percentage of apoptotic cells in COPD. The 
increased apoptosis that persists after smoking cessation 
suggests that this might be a reﬂ  ection of ongoing abnor-
malities remaining after smoking cessation, once COPD 
has been established.
Animal studies have proposed a model of emphysema 
related to increased apoptosis that excludes inﬂ  ammation. 
Animal models, however, do not imitate human diseases 
and gross lung structure differences in the airways limit 
extrapolation of ﬁ  ndings from animals to humans, eg, 
smoking mice are not coughing up sputum (Shapiro 2000a). 
Most human studies on epithelial–endothelial cell apoptosis 
also focus on emphysema. Taking into account that chronic 
bronchitis and emphysema overlap in COPD and that 
patients included in human studies had no a1-antitrypsin 
deﬁ  ciency, it is difﬁ  cult to ignore the chronic bronchitis 
component, although not clearly mentioned in those 
studies, and the possible implication of inﬂ  ammation in 
emphysema. Further studies on COPD including chronic 
bronchitis are needed to examine the contribution of 
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Figure 1 Lung epithelial cell apoptosis. Increased apoptosis of epithelial cells may account for the decreased vascular endothelial growth factor (VEGF) expression, resulting 
in alveolar endothelial cells death.The compromised microcirculation resulting from endothelial cell damage may further promote pneumocyte cell death. Increased elastolytic 
activity in apoptotic lung epithelial cells ampliﬁ  es the destruction of alveolar elastin.The subsequent destruction of the basement membrane and the loss of cell–extracellular 
matrix attachments lead to further apoptosis of the surrounding cells.
Abbreviations: BM, basement membrane; ECM, extracellular matrix.International Journal of COPD 2006:1(2) 167
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inﬂ  ammation and apoptosis in the peripheral airways 
disease.
Neutrophil apoptosis in COPD
An abnormal inflammatory response, and particularly 
the persistent presence in tissue of granulocytes and 
other leukocytes that represent the cellular elements of 
inﬂ  ammation, is considered a central process in the patho-
genesis of COPD (Haslett 1999). Neutrophil accumulation in 
the lungs is a characteristic feature of COPD (Jeffery 1998; 
Saetta 1999; Cosio Piqueras and Cosio 2001). This could 
be explained by two mechanisms: 1) increased neutrophil 
recruitment and chemotaxis, and 2) delayed tissue clearance, 
due either to delayed apoptosis or defective clearance of 
these cells. Apoptosis provides an injury-limiting neutrophil 
clearance mechanism and promotes resolution, rather than 
persistence, of inﬂ  ammation (Haslett 1999). The dysregula-
tion of neutrophil apoptosis in the lungs of COPD patients 
has not been extensively studied.
Human and animal studies
Pletz et al (2004) assessed the apoptosis of peripheral blood 
neutrophils in COPD patients during acute exacerbation 
and found reduced apoptosis of neutrophils in hospitalized 
patients with an acute exacerbation of COPD. The 
apoptosis rate increased progressively during the recovery. 
The apoptosis rates in healthy volunteers were signiﬁ  cantly 
higher than in COPD subjects at admission, but there 
was no signiﬁ  cant difference in apoptosis rate between 
controls and COPD patients at discharge (Pletz et al 
2004). Noguera et al (2004) found that peripheral blood 
neutrophil apoptosis in stable COPD patients occurred 
at a rate similar to that found in healthy individuals 
and smokers with normal lung function. Qualitatively, 
however, there was increased surface expression of 
Mac-1 and decreased surface expression of L-selectin 
in the apoptotic neutrophils of COPD patients (Noguera 
et al 2004). Using ﬂ  ow cytometric techniques, there was a 
nonsigniﬁ  cant trend for reduced apoptosis of neutrophils 
in COPD (Hodge et al 2005). In a study by Turlej et al 
(2001), broncoalveolar lavage ﬂ  uid (BALF) granulocytes 
from heaves-affected horses demonstrated a signiﬁ  cant 
delay in apoptosis compared with blood granulocytes 
from the same horses and blood and BALF granulocytes 
from healthy horses (Turlej et al 2001). Heaves is 
considered to be an animal model for COPD (Raulo 
et al 2001). The rate of apoptosis in blood granulocytes 
from healthy and heaves-affected horses was similar. 
The enhanced survival of BALF granulocytes from sick 
horses was suppressed in the presence of anti-GM-CSF 
receptor antibodies.
Pathophysiologic implications
Apoptosis is an important mechanism controlling functional 
longevity of neutrophils at inﬂ  amed sites (Haslett 1999). 
During apoptosis the neutrophil surface membrane remains 
intact and neutrophils lose the ability to degranulate on 
deliberate external stimulation. Macrophages can clear 
large number of apoptotic neutrophils without leakage of 
potential injurious neutrophil contents into the surrounding 
milieu (Haslett 1999). The uptake of apoptotic neutrophils 
may not only suppress the release of proinflammatory 
agents, such as interleukin (IL)-1β, GM-CSF, IL-8, and 
TNF, but increase macrophage release of agents, such as 
transforming growth factor β (TGF-β), and prostaglandin 
E2, that have suppressive inﬂ  uences on the inﬂ  ammatory 
response (Fadok et al 1998; Haslett 1999). It has been 
demonstrated in vitro that nicotine prolongs neutrophil 
survival in a dose-dependent manner by suppressing 
apoptosis (Aoshiba et al 1996). Several inﬂ  ammatory agents 
known to be elevated in COPD, such as lipopolysaccharide 
(LPS) and GM-CSF, or hypoxic conditions inhibit neutrophil 
apoptosis. Thus, any reduction in neutrophil apoptosis or 
dysregulation of macrophage uptake of apoptotic neutrophils 
could lead to chronic inﬂ  ammation and tissue injury, such as 
that observed in COPD. The observation by Noguera et al 
(2004) of higher surface expression of Mac-1 and lower 
expression of L-selectin in apoptotic neutrophils of COPD 
patients compared with controls is compatible with a higher 
activation status during the apoptosis process. This suggests 
that neutrophils may still contribute to tissue damage in 
COPD patients even during apoptosis (Noguera et al 2004). 
Moreover, increased surface expression of Mac-1 may 
alter the ability of macrophage recognition and removal of 
apoptotic neutrophils (Noguera et al 2004).
A signiﬁ  cant limitation of the studies by Pletz et al (2004) 
and Noguera et al (2004) is that they studied neutrophil 
apoptosis in vitro and in circulating, not lung-derived, 
cells. Peripheral blood neutrophils are expected to exhibit 
different apoptotic behavior than the cells exposed to the 
complex inﬂ  ammatory processes of the COPD lung, and 
in vivo neutrophils are under the dynamic inﬂ  uence of 
several pro-and anti-apoptotic factors simultaneously. The 
above-mentioned studies do not provide enough evidence to 
rule out delayed neutrophil apoptosis as a cause of neutrophil 
accumulation and chronic inﬂ  ammation in COPD lungs.International Journal of COPD 2006:1(2) 168
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Lymphocyte apoptosis in COPD
Studies quantifying the inﬂ  ammation of the airways in 
smokers and deﬁ  ning their phenotype found that the pre-
dominant inﬂ  ammatory cell present was the CD8 + T-cell 
and that their number correlated inversely with the degree 
of airﬂ  ow limitation (Saetta etal 1993; Jeffery 1998; 
Hodge, Hodge, Reynolds, et al 2003; Hogg et al 2004; 
Chrysofakis et al 2004; Tsoumakidou et al 2004). These 
ﬁ  ndings suggest an important role for activated T-cells 
in the pathogenesis of airway abnormalities in COPD. 
A possible mechanism in order to prevent permanent 
damage and remodeling in COPD could be removal of 
excess inﬂ  ammatory cells, including T-cells, by apoptosis, 
as has been suggested in other disease models (Ponomarev 
and Dittel 2005).
Human studies
Hodge, Hodge, Reynolds, et al (2003) assessed apoptosis 
of T lymphocytes isolated from peripheral blood in COPD 
patients, and found significantly increased apoptosis 
of stimulated T-cells, CD4, and CD8, compared with 
controls. There was no signiﬁ  cant difference in levels of 
apoptosis between CD4 and CD8 T-cell subsets in COPD 
patients. An upregulation of Fas, TNF-α, TNF receptor 1, 
and TGF receptor (TGFR) was also observed. Monocyte 
production of TGF-β and release of active TGF-β in the 
peripheral blood were increased. There was a decrease in 
anti-apoptotic bcl2 and IL-7R expression in the peripheral 
blood T-cells in COPD (Hodge et al 2005). The authors 
concluded that the increased T-cell death may be associated 
with both an increase in pro-apoptotic and a decrease in 
anti-apoptotic mediators in the peripheral blood in COPD. 
The same group investigated apoptosis of lung-derived 
T-cells (Hodge et al 2005). They found an increased 
percentage and absolute number of apoptotic BAL-derived 
T-cells in COPD. In addition, there was no signiﬁ  cant 
change in the percentage of T-cells expressing bcl2 or 
bax, although p53 expression and activated caspases by 
BAL-derived CD3 + T-cells were signiﬁ  cantly increased 
in COPD (Hodge et al 2005).
Pathophysiologic implications
Several observations can be made based on the ﬁ  ndings 
by Hodge, Hodge, Reynolds, et al (2003). The increased 
numbers of T-cells in COPD lungs may result from local 
proliferation of T-cells in the lung or enhanced trafﬁ  cking 
from the bloodstream. This trafﬁ  cking also occurs from the 
airways to the bloodstream. Therefore, the authors think 
that it is possible that increased apoptosis of T-cells in the 
peripheral blood in COPD may result either from local 
apoptotic stimuli in the airways or from apoptotic stimuli in 
the peripheral blood (Hodge, Hodge, Reynolds, et al 2003; 
Hodge et al 2005). Increased numbers of apoptotic T-cells 
in the lung, if not effectively cleared, may lead to secondary 
necrosis, which has a pro-inﬂ  ammatory effect. Furthermore, 
the increased secretion of TGF-β by monocytes may be 
attributed to ingestion of increased numbers of apoptotic cells 
(Fadok et al 1998). Increased rates of T-cell apoptosis may 
lead to a defective immune response to infective organisms, 
contributing to the high frequency of infections seen in COPD 
(Hodge et al 2005).
The decrease in the CD4/CD8 ratio seen in COPD cannot 
be explained by a preferential increase in the apoptosis of 
CD4 cells. Recent studies in mice showed that cigarette 
smoke exposure speciﬁ  cally prevented the expansion and 
maximal activation of CD4 T-cells and reduced the number 
of both activated CD4 and CD8 T-cells. Consequently, 
smoke exposure decreased the activated CD4:CD8 T-cell 
ratio from 3 to 1.5 (Robbins et al 2004). The mutagenic 
effect of cigarette smoke on “susceptible” smokers could 
predispose dendritic cells to production of cytotoxic 
CD8 + cells, which in turn induce epithelial cell death and 
apoptosis by perforin (Chrysofakis et al 2004; Tzanakis et al 
2004) (Figure 2).
In conclusion, the observation of increased peripheral 
blood and BAL T lymphocyte apoptosis is not sufﬁ  cient 
to establish a causal relationship with the pathogenesis of 
COPD. Further studies investigating the apoptotic pathways 
in lymphocyte subsets in both airways (induced sputum) and 
peripheral blood in COPD are needed in order to draw safe 
conclusions.
Skeletal muscle wastage and 
apoptosis in COPD
COPD is considered to be a complex lung disease with 
systemic consequences, involving several organs (Oudijk 
et al 2003). Unexplained weight loss and peripheral muscle 
weakness is a major problem for patients with COPD, 
seriously affecting their quality of life. Whereas apoptosis 
in mononucleated cells leads to cell death, in multinucleated 
cells, like the myocyte, it causes cell atrophy (Allen et al 
1997). Increased apoptosis of skeletal muscle could be 
responsible for the skeletal muscle atrophy, the main cause 
of unexplained weight loss in patients with COPD. Gosker 
et al (2003) reported absence of apoptosis of muscle ﬁ  bers, 
at least not at a higher rate in stable COPD patients compared International Journal of COPD 2006:1(2) 169
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with controls (Gosker et al 2003). On the other hand, Agusti 
et al (2002) found that skeletal muscle apoptosis is increased 
in patients with COPD and low body mass index (BMI) 
compared with patients with COPD and normal BMI, healthy 
volunteers, and sedentary subjects undergoing orthopedic 
surgery. They also found that in patients with COPD, BMI 
is inversely related to skeletal muscle apoptosis and that 
this skeletal muscle apoptosis is associated with a lower 
exercise tolerance despite a similar degree of lung function 
impairment. A simple explanation for the different ﬁ  ndings 
of these two studies is that COPD patients included in the 
study by Gosker et al were in a weight stable condition 
with a similar BMI to the control group. Increased skeletal 
muscle apoptosis could not be attributed to aging, inactivity, 
lung function impairment, smoking history, and oral 
steroids (Agusti et al 2002). Underweight patients with 
COPD were younger than those with normal BMI, they 
had similar lung function impairment (including arterial 
hypoxemia) and smoking history, and none had received 
oral steroids. Oxidative stress and systemic inﬂ  ammation 
are both prominent features in COPD and have the potential 
to induce apoptosis (Boots et al 2003; Oudijk et al 2003). 
Moreover, mitochondria play a key role in apoptosis, and 
mitochondrial abnormalities have been reported in skeletal 
muscle in COPD. An increase in the activity of cytochrome 
oxidase (Sauleda et al 1998) and the presence of signiﬁ  cant 
bioenergetic abnormalities (ATS-ERS 1999) have been 
demonstrated in skeletal muscle in COPD. A central 
cytokine in the loss of muscle mass could also be TNF-α 
by stimulating apoptosis via interaction with the TNF-α 
receptor present on the muscle cells (Oudijk et al 2003). 
The role of apoptosis in muscle wasting in COPD is an 
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Figure 2 Oxidative stress of cigarette smoke in “susceptible” smokers activates adaptive immunity, predisposing dendritic cells to clonal expansion of CD4 + and especially 
of cytotoxic CD8 + cells, inducing epithelial cell death by perforin.International Journal of COPD 2006:1(2) 170
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attractive concept that needs further investigation to conﬁ  rm 
the presence of apoptosis in these cells and elucidate possible 
pathogenetic pathways.
Conclusion
Despite the now widely recognized harmful effects of 
tobacco, COPD remains a leading cause of morbidity 
and mortality worldwide. Apoptosis is a highly regulated 
process playing a protective role in physiologic conditions. 
The mechanisms controlling apoptosis act differently on 
different cell populations and different tissue settings. 
Dysregulation of apoptosis has been implicated in many 
lung diseases.
The reviewed studies indicate that apoptosis might play 
a signiﬁ  cant role in COPD pathogenesis, together with 
oxidative stress, protease–antiprotease imbalance, and 
genetic susceptibility. COPD pathology deteriorates even 
after smoking cessation. This observation may be related to 
increased apoptosis in the airways of COPD patients even 
after smoking cessation. These studies provide evidence 
of activation of different apoptotic mechanisms in COPD 
compared with controls, which could also represent a 
protective reaction of the lung to deleterious stimuli. The 
link between apoptosis and COPD pathogenesis remains 
to be proven and extensive research, including also the 
chronic bronchitis component of COPD, is still needed in 
order to verify the above issues. Elucidating the pathogenetic 
mechanisms leading to this condition will help to develop 
new therapeutic strategies against this highly prevalent and 
often fatal disease.
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